Jennifer Lea Moore Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 2801 Parklawn Dr, Midwest City, OK 73110 Phone: 405-733-5437 |
Tony Michael Leonard, BA Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 351 N Air Depot Blvd Ste M, Midwest City, OK 73110 Phone: 405-610-3644 |
Leslie Broadhead, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1390 S Douglas Blvd, Midwest City, OK 73130 Phone: 405-441-1996 Fax: 405-455-5379 |
Mrs. Debra Kay Owen, MA, LMFT CANDIDATE Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 316 S Midwest Blvd, Midwest City, OK 73110 Phone: 405-733-5437 Fax: 405-732-7741 |
Jessica Ann Colls, MS Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1500 S Midwest Blvd, Suite 102, Midwest City, OK 73110 Phone: 501-499-1875 |
Mrs. Mimi Mize Rose Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1500 S Midwest Blvd, Suite 102, Midwest City, OK 73110 Phone: 318-402-6799 |
News Archive
Massachusetts General Hospital (MGH) research has found that insulin production may persist for decades after the onset of type 1 diabetes. Beta cell functioning also appears to be preserved in some patients years after apparent loss of pancreatic function. The study results appear in the March issue of Diabetes Care.
As the human brain develops, neurons leave their birthplace and take a trip to distant locations. Once they reach their final destination, the neurons then send out axons and dendrites - the branches that receive and send messages from other cells.
Researchers at Washington University School of Medicine in St. Louis appear to have discovered a way to make radiation therapy for colorectal cancer more effective by inhibiting a protein found in cancer cells in the gut.
Transcept Pharmaceuticals, Inc. today announced that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on January 20, 2010 to discuss the Complete Response Letter regarding the New Drug Application (NDA) for Intermezzo® (zolpidem tartrate sublingual tablet). As previously announced, the Complete Response Letter, received by Transcept on October 28, 2009, indicated that the FDA could not approve the NDA in its present form.
"Freshman Sen. Marco Rubio is becoming an increasingly critical and hawkish voice on the Obama administration's foreign policy, but he is actually a supporter of U.S. foreign assistance programs and made the case for maintaining this funding to his constituents last week," Foreign Policy's "The Cable" blog writes.
› Verified 3 days ago